Sanofi’s two patents on the cancer drug Taxotere were ruled invalid and unenforceable by a U.S. court today in a victory for generic-drug makers Hospira Inc. and Apotex Inc.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help